## REVIEWER A — Domain Expert

### Scores

| Criteria | Score | Justification |
|----------|-------|---------------|
| Impact | 4 | Solid tool development with clear open-source output; valuable for labs needing automated ablation, but limited to niche community. |
| Approach | 5 | Excellent technical design addressing all previous issues (laser, vibration, optics). Detailed criteria and pre-registration plan. |
| Innovation | 3 | AI-agent layer is interesting but incremental – many groups already use LLMs for microscopy control. The watchdog and fail-safe architecture is good. |
| Preliminary Data | 5 | Comprehensive data on stage repeatability, laser spot size, agent latency, and UV objective transmission. Very convincing. |
| PI & Team | 2 | No information about PI qualifications, institutional support, or team composition. This is a critical gap for a hardware/software project. |
| Feasibility | 4 | Realistic timeline and components, but reliance on commercial APIs (Claude, DeepSeek) and uncertain long-term budget for Experiment A. |
| Experimental Design | 4 | Quantitative success metrics are well-defined. However, biological surrogate gap and lack of power analysis for commissioning are minor. |
| Budget | 5 | Detailed BOM with reasonable costs; 20% contingency included. Well-justified. |
| Clarity | 5 | Document is exceptionally clear, organized, and transparent about scope and limitations. |
| Ethics | 4 | Safety infrastructure described (interlock, goggles, watchdog). Laser safety certification not explicitly mentioned; need OD rating for 355nm. |
| Overall | 4 | Strong technical proposal with minor but fixable weaknesses. |

**Score Sum: 45/55**

---

## REVIEWER B — Fluff/Impact Auditor

### Scores

| Criteria | Score | Justification |
|----------|-------|---------------|
| Impact | 3 | Main output is a validated open-source rig. Useful for a small community; no broader societal or clinical impact. Reframing as “tool development” is honest but limits grant appeal. |
| Approach | 4 | Sound engineering approach. The iterative revision shows responsiveness to criticism. Pre-registration of metrics is solid. |
| Innovation | 2 | Essentially re-creating a standard optogenetics/ablation setup with an LLM wrapper. The “AI-agent” is not novel per se. |
| Preliminary Data | 5 | Strong evidence of technical feasibility. The data are directly relevant and well-documented. |
| PI & Team | 1 | No named PI, no CVs, no institutional letter. This is a major red flag for any funding body. |
| Feasibility | 4 | Hardware procurement and assembly seem achievable. Long-term stability (6-month run) is plausible given the precautions. |
| Experimental Design | 4 | Good quantitative metrics; missing a statistical plan for false-positive rate estimation. |
| Budget | 5 | Very detailed and realistic for a starter grant. No obvious padding. |
| Clarity | 5 | Exceptional clarity – defines what is and is not being validated; no hype. |
| Ethics | 3 | Safety measures are listed but lack certification details (laser class, OSHA compliance). No mention of data privacy or AI ethics. |
| Overall | 3 | A well-written technical plan, but too focused on a narrow tool without broader impact and missing PI credentials. |

**Score Sum: 38/55**

---

## REVIEWER C — Red Team

### Scores

| Criteria | Score | Justification |
|----------|-------|---------------|
| Impact | 2 | The system is a repackaging of existing capabilities. Many commercial systems already offer automated ablation with AI (e.g., Andor, Zeiss). What is the unique value? |
| Approach | 3 | Solid but conventional. The “AI-agent” layer using Claude Code is fragile – depends on API uptime and pricing. Offline fallback is half-baked. |
| Innovation | 1 | No fundamental novelty: LLM-controlled microscopy is a toy example. The real innovation would be in the biological feedback loop, which is deferred. |
| Preliminary Data | 4 | Good technical numbers, but all on fixed samples. No live-cell validation; phototoxicity tests on Elodea are missing. |
| PI & Team | 1 | Completely absent. Who will build this? What is their track record in optics, software, or robotics? This alone would kill most grants. |
| Feasibility | 3 | 6-month continuous run with no oversight is ambitious. The watchdog may fail in edge cases. API cost for 10000+ ablation events could be high. |
| Experimental Design | 3 | Success criteria are all technical. There is no plan to validate that the system actually produces biologically meaningful data (even though it's a tool). |
| Budget | 4 | Underestimated: shipping, customs, spare consumables, and possible laser replacement not included. Also missing software subscription for >1 year. |
| Clarity | 4 | Clear but overly long. Some redundancy with BOM and full description files. |
| Ethics | 2 | Laser safety is mentioned but no evidence of institutional review or compliance with local regulations. AI ethics not addressed (e.g., bias in target detection). |
| Overall | 2 | Technically plausible, but poorly justified as a grant. Lacks team, novelty, and safety assurance. Should be resubmitted with PI info and stronger distinction from existing tools. |

**Score Sum: 28/55**

---

## Combined Verdict

**Combined Score: MIN = 28/55**

**Recommendation: Major Revisions**  
*(Reject if not substantially improved – the missing PI/team and lack of novelty are critical.)*

**Top 3 Actions:**
1. **Provide a complete PI & team description** – include CVs, institutional support, and relevant past projects in optics/software. This is non-negotiable.
2. **Articulate the specific innovation of the AI-agent layer** – clarify how it differs from existing automated microscopy software (e.g., µManager, custom Python scripts). Provide benchmarks or a comparison table.
3. **Demonstrate laser safety compliance** – include a hazard analysis, laser class classification, and institutional approval (or a plan to obtain it). Also address AI ethics for automated decision-making in live samples.